Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis.

Council OD, Ruone S, Mock PA, Khalil G, Martin A, Curlin ME, McNicholl JM, Heneine W, Leelawiwat W, Choopanya K, Vanichseni S, Cherdtrakulkiat T, Anekvorapong R, Martin M, García-Lerma JG.

AIDS. 2019 Dec 1;33(15):2299-2307. doi: 10.1097/QAD.0000000000002390.

PMID:
31764095
2.

HIV-1 genetic diversity to estimate time of infection and infer adherence to pre-exposure prophylaxis.

Council OD, Ruone S, Mock PA, Khalil G, Martin A, Curlin ME, Mcnicholl JM, Heneine W, Leelawiwat W, Choopanya K, Vanichseni S, Cherdtrakulkiat T, Anekvorapong R, Martin M, García-Lerma JG.

AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002390. [Epub ahead of print]

PMID:
31634198
3.

Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.

Massud I, Cong ME, Ruone S, Holder A, Dinh C, Nishiura K, Khalil G, Pan Y, Lipscomb J, Johnson R, Deyounks F, Rooney JF, Babusis D, Park Y, McCallister S, Callebaut C, Heneine W, García-Lerma JG.

J Infect Dis. 2019 Oct 22;220(11):1826-1833. doi: 10.1093/infdis/jiz383.

PMID:
31362305
4.

Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection.

Radzio-Basu J, Council O, Cong ME, Ruone S, Newton A, Wei X, Mitchell J, Ellis S, Petropoulos CJ, Huang W, Spreen W, Heneine W, García-Lerma JG.

Nat Commun. 2019 May 1;10(1):2005. doi: 10.1038/s41467-019-10047-w.

5.

Maintenance and reappearance of extremely divergent intra-host HIV-1 variants.

Wertheim JO, Oster AM, Murrell B, Saduvala N, Heneine W, Switzer WM, Johnson JA.

Virus Evol. 2018 Dec 4;4(2):vey030. doi: 10.1093/ve/vey030. eCollection 2018 Jul.

6.

Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo.

Derby N, Lal M, Aravantinou M, Kizima L, Barnable P, Rodriguez A, Lai M, Wesenberg A, Ugaonkar S, Levendosky K, Mizenina O, Kleinbeck K, Lifson JD, Peet MM, Lloyd Z, Benson M, Heneine W, O'Keefe BR, Robbiani M, Martinelli E, Grasperge B, Blanchard J, Gettie A, Teleshova N, Fernández-Romero JA, Zydowsky TM.

Nat Commun. 2018 Sep 24;9(1):3881. doi: 10.1038/s41467-018-06349-0.

7.

Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy.

Haaland RE, Otieno K, Martin A, Katana A, Dinh C, Slutsker L, Menendez C, Gonzalez R, Williamson J, Heneine W, Desai M.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):912-915. doi: 10.1089/AID.2018.0042. Epub 2018 Oct 17.

8.

Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal Simian Human Immunodeficiency Virus Exposures in Macaques.

Dobard CW, Makarova N, West-Deadwyler R, Taylor A, Dinh C, Martin A, Lipscomb J, Mitchell J, Khalil G, Garcia-Lerma G, Heneine W.

J Infect Dis. 2018 Sep 8;218(8):1284-1290. doi: 10.1093/infdis/jiy301.

9.

Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV.

Garber DA, Mitchell J, Adams D, Guenthner P, Deyounks F, Ellis S, Kelley K, Johnson R, Dobard C, Heneine W, McNicholl J.

PLoS One. 2018 Mar 27;13(3):e0194837. doi: 10.1371/journal.pone.0194837. eCollection 2018.

10.

Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.

Campbell EM, Jia H, Shankar A, Hanson D, Luo W, Masciotra S, Owen SM, Oster AM, Galang RR, Spiller MW, Blosser SJ, Chapman E, Roseberry JC, Gentry J, Pontones P, Duwve J, Peyrani P, Kagan RM, Whitcomb JM, Peters PJ, Heneine W, Brooks JT, Switzer WM.

J Infect Dis. 2017 Nov 27;216(9):1053-1062. doi: 10.1093/infdis/jix307.

11.

Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network.

Wertheim JO, Oster AM, Johnson JA, Switzer WM, Saduvala N, Hernandez AL, Hall HI, Heneine W.

Virus Evol. 2017 Apr 19;3(1):vex008. doi: 10.1093/ve/vex008. eCollection 2017 Jan.

12.

Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.

Makarova N, Henning T, Taylor A, Dinh C, Lipscomb J, Aubert R, Hanson D, Phillips C, Papp J, Mitchell J, McNicholl J, Garcia-Lerma GJ, Heneine W, Kersh E, Dobard C.

AIDS. 2017 Mar 27;31(6):745-752. doi: 10.1097/QAD.0000000000001389.

PMID:
28060011
13.

1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America.

Worobey M, Watts TD, McKay RA, Suchard MA, Granade T, Teuwen DE, Koblin BA, Heneine W, Lemey P, Jaffe HW.

Nature. 2016 Nov 3;539(7627):98-101. doi: 10.1038/nature19827. Epub 2016 Oct 26.

14.

Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs.

Cong ME, Pau CP, Heneine W, García-Lerma JG.

PLoS One. 2016 Nov 2;11(11):e0164821. doi: 10.1371/journal.pone.0164821. eCollection 2016.

15.

Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection.

Massud I, Mitchell J, Babusis D, Deyounks F, Ray AS, Rooney JF, Heneine W, Miller MD, García-Lerma JG.

J Infect Dis. 2016 Oct 1;214(7):1058-62. doi: 10.1093/infdis/jiw312. Epub 2016 Jul 27.

PMID:
27465645
16.

Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire.

Switzer WM, Tang S, Zheng H, Shankar A, Sprinkle PS, Sullivan V, Granade TC, Heneine W.

PLoS One. 2016 Jun 16;11(6):e0157709. doi: 10.1371/journal.pone.0157709. eCollection 2016.

17.

Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United States.

Hall EW, Heneine W, Sanchez T, Sineath RC, Sullivan P.

J Med Internet Res. 2016 May 19;18(5):e111. doi: 10.2196/jmir.5713.

18.

Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups.

Li JF, Linley L, Kline R, Ziebell R, Heneine W, Johnson JA.

AIDS. 2016 Jun 1;30(9):1439-45. doi: 10.1097/QAD.0000000000001099.

PMID:
26990626
19.

Occupational HIV Transmission Among Male Adult Film Performers - Multiple States, 2014.

Wilken JA, Ried C, Rickett P, Arno JN, Mendez Y, Harrison RJ, Wohlfeiler D, Bauer HM, Joyce MP, Switzer WM, Heneine W, Shankar A, Mark KE.

MMWR Morb Mortal Wkly Rep. 2016 Feb 12;65(5):110-4. doi: 10.15585/mmwr.mm6505a3.

20.

Assessment of penile erection methods in rhesus macaques to model pharmacokinetics of antiretroviral drugs and penile infection with simian immunodeficiency virus.

Hayes J, Powell N, Lathrop G, Heneine W, Dobard CW.

J Med Primatol. 2016 Feb;45(1):34-41. doi: 10.1111/jmp.12207. Epub 2016 Jan 18.

PMID:
26778321
21.

Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis.

Radzio J, Henning T, Jenkins L, Ellis S, Farshy C, Phillips C, Holder A, Kuklenyik S, Dinh C, Hanson D, McNicholl J, Heneine W, Papp J, Kersh EN, García-Lerma JG.

J Infect Dis. 2016 May 15;213(10):1541-5. doi: 10.1093/infdis/jiw002. Epub 2016 Jan 6.

22.

Brief Report: HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate.

Ruone S, Paxton L, McLaurin T, Taylor A, Hanson D, Heneine W, Brooks JT, García-Lerma JG.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):129-32. doi: 10.1097/QAI.0000000000000921.

23.

Nondaily preexposure prophylaxis for HIV prevention.

Anderson PL, García-Lerma JG, Heneine W.

Curr Opin HIV AIDS. 2016 Jan;11(1):94-101. doi: 10.1097/COH.0000000000000213. Review.

24.

Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy.

Nishizawa M, Matsuda M, Hattori J, Shiino T, Matano T, Heneine W, Johnson JA, Sugiura W.

PLoS One. 2015 Sep 11;10(9):e0135941. doi: 10.1371/journal.pone.0135941. eCollection 2015.

25.

Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques.

Dobard CW, Sharma S, Cong ME, West R, Makarova N, Holder A, Pau CP, Hanson DL, Novembre FJ, Garcia-Lerma JG, Heneine W.

Retrovirology. 2015 Aug 8;12:69. doi: 10.1186/s12977-015-0195-z.

26.

Short Communication: Practical Experience with Analysis and Design of Repeat Low-Dose SHIVSF162P3 Exposure Studies in Female Pigtail Macaques with Varying Susceptibility During Menstrual Cycling.

Kersh EN, Henning TR, Dobard C, Heneine W, McNicholl JM.

AIDS Res Hum Retroviruses. 2015 Nov;31(11):1166-9. doi: 10.1089/AID.2014.0373. Epub 2015 Aug 6.

27.

Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.

Dobard CW, Taylor A, Sharma S, Anderson PL, Bushman LR, Chuong D, Pau CP, Hanson D, Wang L, Garcia-Lerma JG, McGowan I, Rohan L, Heneine W.

J Infect Dis. 2015 Dec 15;212(12):1988-95. doi: 10.1093/infdis/jiv334. Epub 2015 Jun 12.

28.

Cabotegravir long-acting for HIV-1 prevention.

Andrews CD, Heneine W.

Curr Opin HIV AIDS. 2015 Jul;10(4):258-63. doi: 10.1097/COH.0000000000000161. Review.

PMID:
26049951
29.

Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.

Tsegaye TS, Butler K, Luo W, Radzio J, Srinivasan P, Sharma S, Aubert RD, Hanson DL, Dobard C, Garcia-Lerma JG, Heneine W, McNicholl JM, Kersh EN.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):385-94. doi: 10.1097/QAI.0000000000000642.

30.

Pharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaques.

Massud I, Martin A, Dinh C, Mitchell J, Jenkins L, Heneine W, Pau CP, García-Lerma JG.

J Antimicrob Chemother. 2015 May;70(5):1473-81. doi: 10.1093/jac/dku556. Epub 2015 Jan 27.

31.

The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge.

Radzio J, Spreen W, Yueh YL, Mitchell J, Jenkins L, García-Lerma JG, Heneine W.

Sci Transl Med. 2015 Jan 14;7(270):270ra5. doi: 10.1126/scitranslmed.3010297.

PMID:
25589631
32.

Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa.

Gerberry DJ, Wagner BG, Garcia-Lerma JG, Heneine W, Blower S.

Nat Commun. 2014 Dec 2;5:5454. doi: 10.1038/ncomms6454.

33.

Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques.

Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins L, Heneine W, García-Lerma JG.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):365-9. doi: 10.1097/QAI.0000000000000340.

34.

A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunity.

Ross TM, Pereira LE, Luckay A, McNicholl JM, García-Lerma JG, Heneine W, Eugene HS, Pierce-Paul BR, Zhang J, Hendry RM, Smith JM.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1072-81. doi: 10.1089/AID.2014.0030. Epub 2014 Jul 29.

35.

Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.

Anderson PL, Glidden DV, Bushman LR, Heneine W, García-Lerma JG.

J Antimicrob Chemother. 2014 Sep;69(9):2470-6. doi: 10.1093/jac/dku162. Epub 2014 May 26.

36.

SHIV susceptibility changes during the menstrual cycle of pigtail macaques.

Kersh EN, Henning T, Vishwanathan SA, Morris M, Butler K, Adams DR, Guenthner P, Srinivasan P, Smith J, Radzio J, Garcia-Lerma JG, Dobard C, Heneine W, McNicholl J.

J Med Primatol. 2014 Oct;43(5):310-6. doi: 10.1111/jmp.12124. Epub 2014 Apr 29.

37.

Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.

Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins LT, Hanson D, Heneine W, García-Lerma JG.

AIDS. 2014 Jun 19;28(10):1431-9. doi: 10.1097/QAD.0000000000000294.

PMID:
24759208
38.

Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors.

Dobard C, Sharma S, Parikh UM, West R, Taylor A, Martin A, Pau CP, Hanson DL, Lipscomb J, Smith J, Novembre F, Hazuda D, Garcia-Lerma JG, Heneine W.

Sci Transl Med. 2014 Mar 12;6(227):227ra35. doi: 10.1126/scitranslmed.3007701.

39.

Likely female-to-female sexual transmission of HIV--Texas, 2012.

Chan SK, Thornton LR, Chronister KJ, Meyer J, Wolverton M, Johnson CK, Arafat RR, Joyce PM, Switzer WM, Heneine W, Shankar A, Granade T, Owen MS, Sprinkle P, Sullivan V; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Mar 14;63(10):209-12.

40.

Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial.

Wei X, Hunt G, Abdool Karim SS, Naranbhai V, Sibeko S, Abdool Karim Q, Li JF, Kashuba AD, Werner L, Passmore JA, Morris L, Heneine W, Johnson JA.

J Infect Dis. 2014 Jun 15;209(12):1916-20. doi: 10.1093/infdis/jiu026. Epub 2014 Jan 16.

41.

Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan.

Nishizawa M, Hattori J, Shiino T, Matano T, Heneine W, Johnson JA, Sugiura W.

PLoS One. 2013 Dec 16;8(12):e83150. doi: 10.1371/journal.pone.0083150. eCollection 2013.

42.

Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.

Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL; US Public Health Service Working Group.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):875-92. doi: 10.1086/672271. Erratum in: Infect Control Hosp Epidemiol. 2013 Nov;34(11):1238. Dosage error in article text.

PMID:
23917901
43.

Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues.

Massud I, Aung W, Martin A, Bachman S, Mitchell J, Aubert R, Solomon Tsegaye T, Kersh E, Pau CP, Heneine W, García-Lerma JG.

J Virol. 2013 Aug;87(16):8952-61. doi: 10.1128/JVI.01204-13. Epub 2013 Jun 5.

44.

Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques.

Cong ME, Mitchell J, Sweeney E, Bachman S, Hanson DL, Heneine W, García-Lerma JG.

J Infect Dis. 2013 Aug 1;208(3):463-7. doi: 10.1093/infdis/jit189. Epub 2013 Apr 30.

45.

Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques.

Butler K, Morgan JS, Hanson DL, Adams D, Garcia-Lerma JG, Heneine W, Ellenberger D, Hendry RM, McNicholl J, Johnson WE, Kersh EN.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):1091-4. doi: 10.1089/AID.2012.0383. Epub 2013 Mar 29.

46.

Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients.

Switzer WM, Shankar A, Trimble SR, Thompson AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JM, Heneine W.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):1006-9. doi: 10.1089/AID.2012.0382. Epub 2013 Mar 12.

47.

Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.

Radzio J, Aung W, Holder A, Martin A, Sweeney E, Mitchell J, Bachman S, Pau CP, Heneine W, García-Lerma JG.

PLoS One. 2012;7(12):e50632. doi: 10.1371/journal.pone.0050632. Epub 2012 Dec 4.

48.

Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo.

Switzer WM, Tang S, Ahuka-Mundeke S, Shankar A, Hanson DL, Zheng H, Ayouba A, Wolfe ND, LeBreton M, Djoko CF, Tamoufe U, Esteban A, Heneine W, Peeters M, Wright LL, Muyembe-Tamfum JJ, Wemakoy EO, Mulembakani P, Hoff NA, Rimoin AW.

Retrovirology. 2012 Dec 5;9:100. doi: 10.1186/1742-4690-9-100.

49.

A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus.

Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo SC, Klimas N, Komaroff AL, Montoya JG, Bateman L, Levine S, Peterson D, Levin B, Hanson MR, Genfi A, Bhat M, Zheng H, Wang R, Li B, Hung GC, Lee LL, Sameroff S, Heneine W, Coffin J, Hornig M, Lipkin WI.

MBio. 2012 Sep 18;3(5). pii: e00266-12. doi: 10.1128/mBio.00266-12. Print 2012.

50.

Animal models of antiretroviral prophylaxis for HIV prevention.

García-Lerma JG, Heneine W.

Curr Opin HIV AIDS. 2012 Nov;7(6):505-13. doi: 10.1097/COH.0b013e328358e484. Review.

PMID:
22964889

Supplemental Content

Loading ...
Support Center